Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2023-09
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amarin USD 302.32M 412K 2023-09
Amgen USD 32.75B 152M 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
CSL USD 517M 4.48B 2023-06
Cytokinetics USD 102K 8K 2023-12
Daiichi Sankyo JPY 50B 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Esperion Therapeutics USD 112K 11K 2023-09
Geron USD 545K 3K 2023-12
Grifols EUR 119.6M 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Heron Therapeutics USD 1.41M 212K 2023-09
Intra Cellular Therapies USD 10K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Merck USD 1.79B 0 2023-09
Minerva Neurosciences USD 1000 0 2023-09
Moderna USD 38.2K 100 2023-12
Nektar Therapeutics USD 19K 0 2023-09
Pfizer USD 478M 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Sarepta Therapeutics USD 9K 0 2023-09
United Therapeutics USD 700K 0 2023-12
Vanda Pharmaceuticals USD 57K 0 2023-06



Esperion Therapeutics Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.